【有成精密】The Company's shareholders' meeting approved lifting restrictions on representatives of corporate directors from engaging in competing businesses
Published ・ Source Taiwan | 臺灣證券交易所
有成精密 lifted restrictions on directors from engaging in competing businesses.
【有成精密】Key resolutions passed at the 115 annual shareholders' meeting
Published ・ Source Taiwan | 臺灣證券交易所
有成精密's shareholders' meeting approved the annual financial statements and a proposal to lift restrictions on directors from engaging in competing businesses.
【羅昇】Announcement that the Company's 115 annual shareholders' meeting approved lifting restrictions on directors and their representatives from engaging in competing businesses
Published ・ Source Taiwan | 臺灣證券交易所
羅昇's shareholders' meeting approved a proposal to lift restrictions on directors from engaging in competing businesses.
【禾榮科】The Company has filed an investigational new drug (IND) application with Taiwan's Food and Drug Administration (TFDA), Ministry of Health and Welfare, seeking approval for an academic clinical trial of its B10 L-BPA injection for recurrent locally advanced or metastatic triple-negative breast cancer
Published ・ Source Taiwan | 臺灣證券交易所
禾榮科 filed an application for a clinical trial of its B10 L-BPA injection.
【台苯】 Announces important resolutions of the company's 一一五 annual shareholders' meeting
Published ・ Source Taiwan | 臺灣證券交易所
台苯 held its annual shareholders' meeting, approving the annual financial statements and the proposal for appropriation of profits or offsetting of losses.
秋雨 announces the elected directors for 一一五 and that changes to directors reached 三分之一
Published ・ Source Taiwan | 臺灣證券交易所
秋雨創新 (9929) announced a board election following the expiration of directors’ terms. Executives from 全球人壽 and Deloitte Taiwan joined the new board, with at least 1/3 of the directors changing.
【嘉彰】 Announces that the company's 115 annual shareholders' meeting approved lifting restrictions on directors' competing activities
Published ・ Source Taiwan | 臺灣證券交易所
嘉彰 shareholders approved lifting restrictions on directors' competing activities, allowing directors to serve as independent directors at other companies.
【永冠-KY】 Announces matters concerning holders' exercise of put options for the company's fourth domestic unsecured convertible corporate bonds (abbreviated as 永冠四KY; code: 15894); negotiations with creditors are still ongoing
Published ・ Source Taiwan | 臺灣證券交易所
永冠-KY was unable to repay its convertible bonds on schedule and is negotiating with creditors.
【中再保】Announcement of the resolution at the Company’s 115 annual shareholders’ meeting to lift restrictions on directors’ engagement in competing businesses, including the legal entities they represent
Published ・ Source Taiwan | 臺灣證券交易所
中央再保險 lifts restrictions on directors’ engagement in competing businesses, permitting them to serve as directors of 長榮保險.
【永冠-KY】Announcement that the Company’s fourth domestic unsecured convertible corporate bonds (abbreviated as: 永冠 四KY, code: 15894) will remain suspended from OTC trading in conjunction with other securities, following notification from the Taipei Exchange
Published ・ Source Taiwan | 臺灣證券交易所
Trading in 永冠-KY’s convertible bonds remains suspended due to a debt default.
【永冠-KY】Announcement that the Company received notice from the Taiwan Stock Exchange that its listed securities would be suspended from trading in conjunction with other securities
Published ・ Source Taiwan | 臺灣證券交易所
Trading in 永冠-KY shares will be suspended due to a debt default.
【光群雷】Announcement on the proposed release of directors from non-compete restrictions at the company’s 2026 annual shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
At its 2026 annual shareholders’ meeting, 光群雷射科技 resolved to lift the non-compete restriction on director 郭維武, allowing him to concurrently hold multiple positions at domestic and overseas affiliates.
Companies mentioned：群曜醫電股份有限公司、K Laser China Group、湖南和鑫包裝材料有限公司
【光群雷】Announcement of the results of the election of directors at the Company’s 2026 annual shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
光群雷射科技 held its annual shareholders’ meeting and completed the election of its 13th-term directors. Several directors were re-elected, and new directors were appointed. The changes take effect on May 25, 2026.
【聯上發】Announcement of the resignation of a member of the Compensation Committee
Published ・ Source Taiwan | 臺灣證券交易所
聯上開發 announced that 柯尊仁 resigned as a member of the Compensation Committee, effective 115年6月1日. This is a routine change in membership of a functional committee.
【永崴投控】Announcement of a change in the number of companies held by the company
Published ・ Source Taiwan | 臺灣證券交易所
森崴能源, a subsidiary of 永崴投控, decided to dispose of its shares in 東虹綠能環保科技. The business restructuring will result in the removal of 3 consolidated subsidiaries.
【日月光投控】On behalf of subsidiary 日月光半導體製造(股)公司, announcement of the planned acquisition of a Yangmei factory building from related party 台灣福雷電子(股)公司
Published ・ Source Taiwan | 臺灣證券交易所
日月光半導体 will acquire a factory in Yangmei District, Taoyuan City, from its subsidiary 台湾福雷電子 for NT$566 million to expand production capacity at its Zhongli plant. The board has approved the deal.
【日月光投控】On behalf of subsidiary 日月光半導體製造(股)公司, announcement that its board of directors resolved to set the ex-dividend record date and payment date
Published ・ Source Taiwan | 臺灣證券交易所
日月光投控 subsidiary 日月光半導體 resolved to distribute NT$17.5 billion in cash dividends to its parent company. The ex-dividend record date is 115年7月28日, and the payment date is 115年7月29日.
【日月光投控】On behalf of subsidiary 日月光半導體製造(股)公司 (the “日月光公司”), announcement of key resolutions passed by its board of directors, acting in place of the shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
日月光半導體 held its annual shareholders’ meeting on 115年5月25日, approved the annual financial report, and passed a resolution to distribute NT$17.5 billion in cash dividends to its parent company.
【中石化】On behalf of 鼎越, announcement that a letter was received from the Taipei City Government providing relevant explanations regarding the review of the urban design and land-use development permit application for the “鼎越開發商辦大樓 New Construction Project.”
Published ・ Source Taiwan | 臺灣證券交易所
鼎越開發 announced that the Taipei City Government had requested revisions to the floor area ratio for its construction project. The company is considering how to respond within the deadline.
【正文】Announcement of matters related to the record date for the Company’s cash dividend ex-dividend
Published ・ Source Taiwan | 臺灣證券交易所
The Company announced the ex-dividend record date for its cash dividend and the related schedule. The cash dividend is approximately NT$0.5 per common share, with payment scheduled for 115年7月14日.
【正文】Announcement of the additional appointment of a member to the Company’s Sustainability Development Committee
Published ・ Source Taiwan | 臺灣證券交易所
At its board meeting on May 25, 115, the company appointed 曾祥器 as a member of its Sustainability Development Committee. He will bring his expertise as an independent director to the role.
【正文】Announcement of a change in the membership of the Company’s Audit Committee
Published ・ Source Taiwan | 臺灣證券交易所
A change in the membership of the Audit Committee was announced. 曾祥器, a professor in the Department of Physics at Chung Yuan Christian University, was appointed following a by-election for an independent director.
【正文】Announcement that the company’s board elected its chairperson
Published ・ Source Taiwan | 臺灣證券交易所
正文科技’s board of directors approved a personnel matter on 115年5月25日. 陳鴻文 was reappointed as chairman, and his director status was changed from a corporate representative to an individual director.
【正文】Approval at the company’s 115 annual shareholders’ meeting of a proposal to release directors from non-compete restrictions
Published ・ Source Taiwan | 臺灣證券交易所
正文科技 shareholders approved lifting the non-compete restriction on Chairman 陳鴻文, with 87.79% voting in favor. The move will not adversely affect the Company’s finances or operations.
【日月光投控】On behalf of subsidiary 台灣福雷電子(股)公司 (the “福雷公司”), announcement of key resolutions passed by its board of directors, acting in place of the shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
台湾福雷電子, a subsidiary of 日月光投控, held its regular shareholders' meeting. The 2025 financial statements and other matters were approved, and no cash dividend was declared.
百達-KY added an endorsement guarantee of approximately 300 million yuan for its affiliate BIGL Asia to address liabilities related to the disposal of 鏷偉科技（深圳）.
Companies mentioned：百達-KY、BIGL Asia Pte. Ltd.、Broadway Industrial Group Limited、鏷偉科技（無錫）有限公司、鏷偉科技（深圳）有限公司
【正文】Announcement of the elected candidates in the by-election of directors (including independent directors) at the Company’s 115 annual shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
正文科技 held by-elections for directors and independent directors at its shareholders’ meeting. 陳鴻文 was elected as a director and 曾祥器 as an independent director, with the appointments taking effect on 115年5月25日.
【正文】Announcement of key resolutions passed at the Company’s 115 annual shareholders’ meeting
Published ・ Source Taiwan | 臺灣證券交易所
The company approved financial statements and held a by-election for directors at its shareholders' meeting, strengthening its corporate governance framework.
【北極星藥業-KY】On behalf of subsidiary 英屬開曼群島商霖揚藥業股份有限公司, announcement of a change in directors
Published ・ Source Taiwan | 臺灣證券交易所
A change in natural-person directors was announced at 霖揚藥業, a subsidiary of 北極星藥業-KY. 陳鴻文 resigned following a change in appointment by the parent company, and 侯玉祥 will succeed him.
【北極星藥業-KY】Announcement of the convener of the company’s Remuneration Committee
Published ・ Source Taiwan | 臺灣證券交易所
北極星藥業-KY re-elected 趙應誠 as convener of its Remuneration Committee. The appointment followed the end of the previous term and took effect on May 25, 2026.
【北極星藥業-KY】Announcement of the convener of the company’s Audit Committee
Published ・ Source Taiwan | 臺灣證券交易所
北極星藥業-KY replaced 魏宗德 with 張志剛 as convener of its Audit Committee. The change followed the end of the term, and the new appointment took effect on May 25, 2026.